Achillion Pharma (ACHN) Posts Narrower-than-Expected Q3 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Achillion Pharma (ACHN) Posts Narrower-than-Expected Q3 Loss

Achillion (ACHN) Decline Called Over-Reaction at Deutsche Bank

November 4, 2014 11:23 AM EST

Deutsche Bank maintained a Buy rating on Achillion Pharmaceuticals (NASDAQ: ACHN) with a price target of $17. The stock declined Tuesday after it reported Q3 results. Analyst Alethia Young thinks today's decline on concerns about the timing of 3422 data is an overreaction.

"Based on our call volume, we have gotten questions as to whether this is a delay or not. We have always... More

Achillion Pharma (ACHN): Hard to Read Anything into Absence of 3422 Data, Says Wells Fargo

November 4, 2014 10:17 AM EST

Wells Fargo maintained an Outperform rating on Achillion Pharmaceuticals (NASDAQ: ACHN) with a price target of $15-$17. Comments follow Q3 results. Analyst Brian Abrahams noted Achillion did not provide data on its 3422 nuc, but he thinks it's on track to be... More